Brazil sets up new committee to take forward microbial resistance technology policies
This article was originally published in Clinica
Developers of antimicrobial coatings and related technologies have a new committee to look to in Brazil for policy-making in this area. Healthcare products regulatory agency Anvisa has this week formalised the creation of the microbial resistance technical committee, Catrem (Câmara Técnica de Resistência Microbiana).
You may also be interested in...
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.